BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15706997)

  • 1. Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center.
    Rubboli A; Colletta M; Sangiorgio P; Di Pasquale G
    Ital Heart J; 2004 Dec; 5(12):919-25. PubMed ID: 15706997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention.
    Rubboli A; Colletta M; Herzfeld J; Sangiorgio P; Di Pasquale G
    Coron Artery Dis; 2007 May; 18(3):193-9. PubMed ID: 17429293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
    Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician.
    Rubboli A; Verheugt FW
    Int J Cardiol; 2008 Jan; 123(3):234-9. PubMed ID: 17434621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience.
    Halbfass P; Janko S; Dorwarth U; Riess G; Antoni D; Hoffmann E
    Europace; 2009 Jul; 11(7):957-60. PubMed ID: 19493910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
    Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
    Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
    Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
    Rubboli A; Milandri M; Castelvetri C; Cosmi B
    Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].
    Silber S; Richartz BM; Brilmayer M;
    Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
    Denardo SJ; Davis KE; Tcheng JE
    Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry).
    Rubboli A; Magnavacchi P; Guastaroba P; Saia F; Vignali L; Giacometti P; Franco N; Benassi A; Varani E; Campo G; Manari A; De Palma R; Marzocchi A
    Am J Cardiol; 2012 May; 109(10):1411-7. PubMed ID: 22342850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting.
    Rubboli A; Di Pasquale G
    Future Cardiol; 2006 Mar; 2(2):205-13. PubMed ID: 19804077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.